OK, i asked the youtube channel to put your response back up. I'm not sure why it was removed but you should be able to have a response. For the record, i still don't think you've disproven anything from our report. $ZJK

Clearly, $AUID was manipulated up for their offering today. No guidance at all in their last earnings call, next quarterly earnings will likely be about the same, $200K in revs. The stock is toast.

I guess $TELO insiders didn't have the balls i was expecting. I wanted a war, to see how high they could squeeze it. But the day after we posted this, the stock shriveled up.🤷‍♂️

Wow. $AUID is dirty to the core. We've already filed 2 whistleblower complaints against the company for lying about its projected revenue. Now, it likely hired this guy, Neil Bhatia, who is a convicted felon, to pump and lie about AUID, saying that the Trumps own shares. Are

Tomorrow morning we are publishing on a clinical stage MedTech company that we believe is massively overvalued.

$PLSE just yesterday filed on clinicaltrials.gov, ID: NCT06959121 that they will start recruiting in July for their clamp. As we showed in our report, they first filed a 510(K) with the FDA on 1/2/24, then the FDA requested clinical data in July 2024. They then demoted their

$PLSE is now lower than the lowest price on the day we published a week ago, 5/6/25. So if you shorted anytime that day and held, you'd be green now. Our reports usually work and we're right, they just sometimes take a little time. $ZJK has been rough, that one has been

Breaking News Report: Aytu BioPharma’s ADHD Drugs Will Be Replaced By Generics from Teva Pharma Over The Next Year $AYTU Read one-page report here: whitediamondresearch.com/archive/breaki…

A winning day for WDR. $PLSE stock has dropped and an executive announces he's selling shares. $AUID has fallen to its $4.50 offering price from 3/31/25.

Interesting new analyst report on $PLSE yesterday. It was titled: Pulse Biosciences: nsPFA—Platform Technology with Multiple Shots on Goal; Initiating with Outperform and $22 PT -- Oppenheimer OK, so a $1B market cap company has "multiple shots on goal"? Not a good

For new traders who are unfamiliar with $TELO. It's a total scam. Our report proved to be true, they are perpetually stuck in the preclinical phase: whitediamondresearch.com/research/telom…

This group is run by talented college kids and already has a great track record for both long and short ideas. We're subscribing!

It's $BZAI. Wow these guys uncovered another fraud. Great future ahead for these kids.

We were just told about $BZAI today by Ragnarok Research, which we are subscribing to, and we shorted some today. Their research is compelling, and we believe this company could possibly be a total fraud, and could see 90%+ downside in its currently hefty $300M+ market cap.

$PLSE - We're still confident this is one of the best short opportunities in the market today, and it's our biggest short position. It's up a lot on the earnings call from 8/12, but we didn't see much progress there. It will still be a rocky road for a short, so have a good